Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2024 Aug;131(9):1259-1269.
doi: 10.1111/1471-0528.17775. Epub 2024 Feb 13.

Evaluating Chlamydia trachomatis and Neisseria gonorrhoeae screening and treatment among asymptomatic pregnant women to prevent preterm birth and low birthweight in Gaborone, Botswana: A secondary analysis from a non-randomised, cluster-controlled trial

Affiliations
Controlled Clinical Trial

Evaluating Chlamydia trachomatis and Neisseria gonorrhoeae screening and treatment among asymptomatic pregnant women to prevent preterm birth and low birthweight in Gaborone, Botswana: A secondary analysis from a non-randomised, cluster-controlled trial

Adriane Wynn et al. BJOG. 2024 Aug.

Abstract

Objective: To evaluate the impact of screening and treating asymptomatic pregnant women for Chlamydia (C.) trachomatis and Neisseria (N.) gonorrhoeae infections on the frequency of preterm birth or low birthweight infants in Botswana.

Design: Non-randomised, cluster-controlled trial.

Setting: Four antenatal care clinics in Gaborone, Botswana.

Population: Pregnant women aged ≥15 years, attending a first antenatal care visit, ≤27 weeks of gestation and without urogenital symptoms were eligible.

Methods: Participants in the intervention clinics received screening (GeneXpert®, Cepheid) during pregnancy and at the postnatal visit. Participants in the standard-of-care clinics received screening at the postnatal visit only. We used multivariable logistic regression and post-estimation predictive margins analysis. Post-hoc analysis was conducted among sub-samples stratified by parity.

Main outcome measures: Preterm birth (<37 weeks of gestation) and low birthweight (<2500 g).

Results: After controlling for parity, hypertension, antenatal care visits and clinic site, the predicted prevalence of preterm birth or low birthweight was lower in the intervention arm (11%) compared with the standard-of-care arm (16%) (adjusted odds ratio [aOR] 0.59; 95% confidence interval [CI] 0.28-1.24). In post-hoc analysis, the intervention was more effective than the standard-of-care (aOR 0.20; 95% CI 0.07-0.64) among nulliparous participants.

Conclusion: A C. trachomatis and N. gonorrhoeae infection screening and treatment intervention among asymptomatic pregnant women may have reduced preterm birth or low birthweight outcomes, but results were not statistically significant. Post-hoc analysis found that the intervention reduced adverse outcomes among nulliparous participants.

Keywords: Chlamydia trachomatis; Neisseria gonorrhoeae; low birthweight; pregnancy; preterm birth; sexually transmitted infections; syndromic management.

PubMed Disclaimer

Conflict of interest statement

Disclosure of interests

Dr Klausner reports personal fees from Cepheid, during the conduct of the study, and personal fees from Danaher, outside the submitted work. None of the other authors declares a conflict of interest. Completed disclosure of interests forms are available to view online as supporting information.

Figures

Figure 1:
Figure 1:
Flow of participants in the Maduo study, February 2021-December 2022, Gaborone, Botswana Notes: SoC=Standard-of-Care, PTB=preterm birth, LBW=low birth weight
Figure 2.
Figure 2.
Predicted prevalence of preterm birth/low birth weight, preterm birth, and low birth weight by intervention arm assignment. Notes: PTB=preterm birth; LBW=low birth weight; SoC=Standard-of-Care assignment; Intv=Intervention assignment. Predicted prevalence using post-estimation predictive margins analysis resulting from multivariable logistic regression controlling for parity, antenatal care visits, hypertension, and clinic.

Similar articles

Cited by

References

    1. United Nations Inter-agency Group for Child Mortality Estimation (UNIGME). Levels & Trends in Child Mortality: Report 2022, Estimates developed by the United Nations Inter-agency Group for Child Mortality Estimation. New York; 2023. - PMC - PubMed
    1. Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals. The Lancet Child & adolescent health. 2022;6(2):106–15. - PMC - PubMed
    1. Katz J, Lee AC, Kozuki N, Lawn JE, Cousens S, Blencowe H, et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382(9890):417–25. - PMC - PubMed
    1. Wynn A, Bristow CC, Cristillo AD, Murphy SM, van den Broek N, Muzny C, et al. Sexually Transmitted Infections in Pregnancy and Reproductive Health: Proceedings of the STAR Sexually Transmitted Infection Clinical Trial Group Programmatic Meeting. Sex Transm Dis. 2019. - PMC - PubMed
    1. Grant JS, Chico RM, Lee AC, Low N, Medina-Marino A, Molina RL, et al. Sexually Transmitted Infections in Pregnancy: A Narrative Review of the Global Research Gaps, Challenges, and Opportunities. Sex Transm Dis. 2020;47(12):779–89. - PMC - PubMed

Publication types

MeSH terms

Substances